| April 25,
2003
Bayer: First-quarter sales improve by more than 4 percent – Operating result also up year on year
Double-digit growth in operating result predicted for 2003 / Lipobay/Baycol: more settlement agreements concluded in U.S.
Werner Wenning at the Bayer AG Annual Stockholders' Meeting in Cologne:
Very encouraging sales and earnings performance / Improving earning power through internal measures
All goals accomplished and in some cases exceeded in 2002 / The right course is set for the future
Stockholders' Meeting
We have set the right course for the future.
Address by Werner Wenning, Chairman of the Board of Management
Personnel change on Bayer's Supervisory Board
Jürgen Weber to succeed Dr. Wolfgang Reitzle
Forward-Looking Statements
This news release contains forward-looking statements based on current assumptions
and forecasts made by Bayer Group management. Various known and unknown risks, uncertainties, and other factors could lead to material
differences between the actual future results, financial situation, development or performance of the company, and the estimates given
here. These factors include those discussed in our public reports filed with the Frankfurt Stock Exchange and with the U.S. Securities
and Exchange Commission (including our Form 20-F).
The company assumes no liability whatsoever to update these forward-looking statements
or to conform them to future events or developments.
Contact:
Tricia McKernan
Bayer Biological Products
+1-(0)919/316-6316
E-mail: tricia.mckernan.b@bayer.com
|
